Mingli Peng相关文献与解析，生知库 | 链接生命科学的每一步

Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases

自身免疫性肝病患者接种灭活SARS-CoV-2疫苗（初次接种和加强接种）后的安全性和免疫原性

期刊:Journal of Clinical and Translational Hepatology

doi:10.14218/JCTH.2023.00049

Zhiwei Chen ，Yuting Wang ，Taiyu He ，Hu Li ，Ling Ao ，Qingbo Pan ，Yingzhi Zhou ，Qian Zhu ，Dejuan Xiang ，Gaoli Zhang ，Ning Ling ，Min Chen ，Peng Hu ，Mingli Peng ，Dachuan Cai ，Dazhi Zhang ，Hong Ren

The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels

Adelmidrol 的抗纤维化功效取决于肝脏 PPARγ 水平

期刊:Biomedicine & Pharmacotherapy

影响因子:6.9

doi:10.1016/j.biopha.2023.115051

Huanyu Xiang, Jing Xiao, Zilin Sun, Zongyi Liu, Junhao Zhang, Hongyan Xiang, Hong Ren, Peng Hu, Mingli Peng

信号转导

发表日期：2023

文献求助收藏

Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study

HIV 感染者接种灭活 SARS-CoV-2 初次和加强疫苗后的动态免疫原性：一项纵向观察研究

期刊:Journal of Medical Virology

影响因子:6.8

doi:10.1002/jmv.28730

Ting Lu, Zhiwei Chen, Yu Cao, Ling Ao, Zisheng Li, Xiaoyi Gu, Xingqian Ren, Yixuan Wang, Gaoli Zhang, Dejuan Xiang, Min Chen, Dachuan Cai, Peng Hu, Dazhi Zhang, Mingli Peng, Xiaofeng Shi, Hong Ren

Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection

慢性乙型肝炎感染儿童接种灭活新冠疫苗后长达1年的体液免疫反应

期刊:Frontiers in Cellular and Infection Microbiology

影响因子:4.6

doi:10.3389/fcimb.2023.1201101

Yingzhi Zhou ，Zhiwei Chen ，Yi He ，Xiaorong Peng ，Yunan Chang ，Aoxue Tan ，Hu Li ，Dachuan Cai ，Peng Hu ，Min Chen ，Mingli Peng ，Hongmei Xu ，Hong Ren

GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota

GW9662 通过抑制 PPARγ/CD36 通路和改变肠道菌群来改善非酒精性脂肪性肝炎

期刊:European Journal of Pharmacology

影响因子:4.2

doi:10.1016/j.ejphar.2023.176113

Jing Xiao, Huanyu Xiang, Hongyan Xiang, Zilin Sun, Jing Xu, Hong Ren, Peng Hu, Mingli Peng

Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection

慢性乙型肝炎病毒感染患者对流感疫苗的抗体反应降低，但对后续SARS-CoV-2疫苗的抗体反应增强。

期刊:Immunity Inflammation and Disease

影响因子:3.1

doi:10.1002/iid3.759

Taiyu He ，Ning Ling ，Gaoli Zhang ，Dejuan Xiang ，Peng Hu ，Mingli Peng ，Dachuan Cai ，Dazhi Zhang ，Min Chen ，Hong Ren

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV

在艾滋病毒感染者中，灭活SARS-CoV-2疫苗的安全性和免疫原性

期刊:Emerging Microbes & Infections

影响因子:8.4

doi:10.1080/22221751.2022.2059401

Ling Ao ，Ting Lu ，Yu Cao ，Zhiwei Chen ，Yuting Wang ，Zisheng Li ，Xingqian Ren ，Pan Xu ，Mingli Peng ，Min Chen ，Gaoli Zhang ，Dejuan Xiang ，Dachuan Cai ，Peng Hu ，Xiaofeng Shi ，Dazhi Zhang ，Hong Ren

Dynamics of the gut-liver axis in rats with varying fibrosis severity

不同纤维化严重程度大鼠的肠肝轴动态

期刊:International Journal of Biological Sciences

影响因子:8.2

doi:10.7150/ijbs.69833

Hongyan Xiang, Zongyi Liu, Huanyu Xiang, Dejuan Xiang, Shuang Xiao, Jing Xiao, Wei Shen, Peng Hu, Hong Ren, Mingli Peng

信号转导

发表日期：2022

文献求助收藏

Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer

灭活和肽类SARS-CoV-2疫苗在内分泌相关癌症患者中的短期安全性和免疫原性

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2022.1028246

Rui Song ，Li Liu ，Qingbo Pan ，Jin Liu ，Jiahe Tan ，Juan Deng ，Qin Deng ，Zijin Lin ，Min Chen ，Mingli Peng ，Hong Ren ，Jia Ming

FSP1 and CoQ10 have the potential to serve as biomarkers for severe preeclampsia

FSP1 和 CoQ10 有潜力作为重度子痫前期的生物标志物

Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases

自身免疫性肝病患者接种灭活SARS-CoV-2疫苗（初次接种和加强接种）后的安全性和免疫原性

The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels

Adelmidrol 的抗纤维化功效取决于肝脏 PPARγ 水平

Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study

HIV 感染者接种灭活 SARS-CoV-2 初次和加强疫苗后的动态免疫原性：一项纵向观察研究

Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection

慢性乙型肝炎感染儿童接种灭活新冠疫苗后长达1年的体液免疫反应

GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota

GW9662 通过抑制 PPARγ/CD36 通路和改变肠道菌群来改善非酒精性脂肪性肝炎

Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection

慢性乙型肝炎病毒感染患者对流感疫苗的抗体反应降低，但对后续SARS-CoV-2疫苗的抗体反应增强。

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV

在艾滋病毒感染者中，灭活SARS-CoV-2疫苗的安全性和免疫原性

Dynamics of the gut-liver axis in rats with varying fibrosis severity

不同纤维化严重程度大鼠的肠肝轴动态

Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer

灭活和肽类SARS-CoV-2疫苗在内分泌相关癌症患者中的短期安全性和免疫原性